Acumen Pharmaceuticals Inc (ABOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2017 | 12-2006 | 12-2005 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 6,552 | N/A | N/A | N/A |
| Receivables | 30 | N/A | N/A | N/A |
| TOTAL | $7,178 | $N/A | $N/A | $N/A |
| Non-Current Assets | ||||
| Other Non-Current Assets | 144 | 0 | 0 | 0 |
| TOTAL | $144 | $N/A | $N/A | $N/A |
| Total Assets | $7,322 | $N/A | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 223 | 0 | 0 | 0 |
| Accrued Expenses | 542 | N/A | N/A | N/A |
| TOTAL | $765 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 17,977 | 0 | 0 | 0 |
| TOTAL | $17,977 | $N/A | $N/A | $N/A |
| Total Liabilities | $18,742 | $N/A | $N/A | $N/A |
| Shareholders' Equity | ||||
| Retained earnings | -19,640 | N/A | N/A | N/A |
| TOTAL | $-11,420 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $7,322 | $0 | $0 | $0 |